Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation

Am J Hematol. 2015 Jul;90(7):E133-4. doi: 10.1002/ajh.24013.

Aurélie Jaspers¹, Frédéric Baron^{1

2}, Johan Maertens³, Bernard De Prijck^{1

4}, Rik Schots⁵, Christophe Bonnet¹, Kaoutar Hafraoui¹, Évelyne Willems¹, Sophie Servais^{1

2}, Georges Fillet¹, Yves Beguin^{1

2}

¹ Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
² Giga-Research, University of Liège, Liège, Belgium.
³ Clinical Hematology, Acute Leukemia & Stem Cell Transplantation Unit, , University Hospital Gasthuisberg, Leuven, Belgium.
⁴ Division of Hematology, Department of Medicine, CHR La Citadelle, Liège, Belgium.
⁵ Department of Clinical Hematology and Stem Cell Laboratory, Universitair Ziekenhuis Brussel, Belgium.

No abstract available

Publication types